TaiMed Biologics Inc.
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study (NCT07215468) | TaiMed Biologics Inc. | 2025-12-16 |
| TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals (NCT05275998) | TaiMed Biologics Inc. | 2022-07-05 |
| Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants (NCT04027387) | TaiMed Biologics Inc. | 2019-12-14 |
| Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection (NCT03913195) | TaiMed Biologics Inc. | 2019-05-30 |
Track TaiMed Biologics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.